Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Multiple Myeloma

  • You have access
    A higher increase in FDG uptake in whole bone marrow of multiple myeloma patients from early to delayed pre-treatment scans is associated with poor response to treatment and inferior survival
    Mahdi Zirakchian Zadeh, Brian Ostergaard, William Raynor, Cyrus Ayubcha, Oswaldo Acosta-Montenegro, Dani Yellanki, Siavash Mehdizadeh Seraj, Chaitanya Rojulpote, Oke Gerke, Caius Constantinescu, Thomas Werner, Hongming Zhuang, Poul Flemming Hoilund-Carlsen and Abass Alavi
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 21;
  • You have access
    [18F]Florbetaben positron emission tomography for imaging amyloidosis in multiple myeloma patients
    Minjung Seo, Hee Jeong Cha, Sang Hyuk Park, Jae Cheol Jo and Seol Hoon Park
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 17;
  • You have access
    11C-acetate PET/CT has a significantly higher correlation with FISH test than 18F-FDG PET/CT in risk stratification of multiple myeloma
    Chi-Lai Ho, Sirong Chen, William Cheung, Yim Lung Leung, Kam Chau Cheng, Ka Nin Wong, Yuet Hung Wong, Kwan Kit Wu and Hin Suen Raymond Liang
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 20;
  • You have access
    Evaluation of myeloma bone disease by means of 18F-sodium fluoride PET/CT
    Mahdi Zirakchian Zadeh, Brian Ostergaard, Siavash Mehdizadeh Seraj, Cyrus Ayubcha, William Raynor, Oke Gerke, Caius Constantinescu, Thomas Werner, Hongming Zhuang, Poul Flemming Hoilund-Carlsen and Abass Alavi
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 24;
  • You have access
    68Ga-pentixafor PET/CT in the visual and quantitative evaluation of multiple myeloma: a comparison to 18F-FDG PET/CT imaging
    Qingqing Pan, Yaping Luo, Xinxin Cao and Fang Li
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 18;
  • You have access
    Baseline global splenic uptake of FDG in multiple myeloma patients: a higher uptake is associated with inferior overall survival
    Mahdi Zirakchian Zadeh, Duc Nguyen, Brian Ostergaard, Cyrus Ayubcha, Abdullah Al-zaghal, William Raynor, Chaitanya Rojulpote, Oke Gerke, Caius Constantinescu, Thomas Werner, Hongming Zhuang, Poul Flemming Hoilund-Carlsen and Abass Alavi
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 22;
  • You have access
    Comparison of 11C-Choline and 11C-Methionine-PET/CT in Multiple Myeloma
    Malte Kircher, Constantin Lapa and Andreas Buck
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 19;
  • You have access
    Evaluation of response to treatment in multiple myeloma patients by a semi-automated FDG-PET/CT quantification method
    Mahdi Zirakchian Zadeh, Brian Ostergaard, William Raynor, Cyrus Ayubcha, Oswaldo Acosta-Montenegro, Siavash Mehdizadeh Seraj, Oke Gerke, Caius Constantinescu, Thomas Werner, Hongming Zhuang, Poul Flemming Hoilund-Carlsen and Abass Alavi
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 23;
SNMMI

© 2025 SNMMI

Powered by HighWire